吸入型胰岛素
Inhaled insulins.
作者信息
Ghosh Sujoy, Collier Andrew
机构信息
Ayr Hospital, Dalmellington Road, Ayr, Ayrshire, UK.
出版信息
Postgrad Med J. 2007 Mar;83(977):178-81. doi: 10.1136/pgmj.2006.053868.
Abstract
As a result of knowledge gained from the management of asthma with inhalers and nebulisers, pulmonary delivery devices for insulin have been developed. Particle size of the aerosol particularly influences drug delivery. Although several pharmaceutical companies are developing different systems, Pfizer have launched the first inhaled insulin (Exubera). Clinical trials have taken place in patients with both type 1 and type 2 diabetes, but have shown similar glucose control as subcutaneous insulin delivery. However, patient satisfaction does seem to be increased in patients taking inhaled insulins. Further studies are needed to investigate compliance, side-effect profiles, quality of life, long-term glycaemia control and cost effectiveness.
摘要
由于从使用吸入器和雾化器治疗哮喘中获得的知识，胰岛素肺部给药装置得以研发。气雾剂的颗粒大小对药物递送有特别影响。尽管多家制药公司正在研发不同的系统，但辉瑞已推出首款吸入式胰岛素（Exubera）。1型和2型糖尿病患者均已进行临床试验，结果显示其血糖控制效果与皮下注射胰岛素相似。然而，吸入胰岛素治疗的患者满意度似乎有所提高。还需要进一步研究来调查依从性、副作用情况、生活质量、长期血糖控制以及成本效益。
相似文献
1
Inhaled insulins.吸入型胰岛素
Postgrad Med J. 2007 Mar;83(977):178-81. doi: 10.1136/pgmj.2006.053868.
2
The clinical effectiveness and cost-effectiveness of inhaled insulin in diabetes mellitus: a systematic review and economic evaluation.吸入性胰岛素治疗糖尿病的临床疗效和成本效益：系统评价与经济评估
Health Technol Assess. 2007 Sep;11(33):1-126. doi: 10.3310/hta11330.
3
Inhaled insulin in diabetes mellitus.糖尿病中的吸入式胰岛素。
Cochrane Database Syst Rev. 2004(3):CD003890. doi: 10.1002/14651858.CD003890.pub2.
4
WITHDRAWN: Inhaled insulin in diabetes mellitus.撤回：糖尿病中的吸入式胰岛素。
Cochrane Database Syst Rev. 2009 Jan 21;2009(1):CD003890. doi: 10.1002/14651858.CD003890.pub3.
5
Inhaled insulin in diabetes mellitus.糖尿病中的吸入型胰岛素。
Cochrane Database Syst Rev. 2003(3):CD003890. doi: 10.1002/14651858.CD003890.
6
Exubera: inhaled insulin for diabetes.依克苏玛：用于糖尿病的吸入式胰岛素
Drug Ther Bull. 2007 Jan;45(1):5-8. doi: 10.1136/dtb.2007.4515.
7
Future prospect of insulin inhalation for diabetic patients: The case of Afrezza versus Exubera.糖尿病患者胰岛素吸入的未来前景：以 Afrezza 与 Exubera 为例。
J Control Release. 2015 Oct 10;215:25-38. doi: 10.1016/j.jconrel.2015.07.025. Epub 2015 Jul 26.
8
Meta-analysis: efficacy and safety of inhaled insulin therapy in adults with diabetes mellitus.荟萃分析：吸入式胰岛素疗法对成年糖尿病患者的疗效与安全性
Ann Intern Med. 2006 Nov 7;145(9):665-75. doi: 10.7326/0003-4819-145-9-200611070-00009.
9
Inhaled human [rDNA origin] insulin, a novel formulation for diabetes mellitus.吸入式人源[重组DNA来源]胰岛素，一种用于糖尿病的新型制剂。
J Clin Pharmacol. 2007 Jul;47(7):890-903. doi: 10.1177/0091270007301798.
10
Insulin inhalation--Pfizer/Nektar Therapeutics: HMR 4006, inhaled PEG-insulin--Nektar, PEGylated insulin--Nektar.胰岛素吸入剂——辉瑞/耐科斯特治疗公司：HMR 4006，吸入型聚乙二醇化胰岛素——耐科斯特，聚乙二醇化胰岛素——耐科斯特。
Drugs R D. 2004;5(3):166-70. doi: 10.2165/00126839-200405030-00007.
引用本文的文献
1
The Discovery of Insulin: An Important Milestone in the History of Medicine.胰岛素的发现：医学史上的一个重要里程碑。
Front Endocrinol (Lausanne). 2018 Oct 23;9:613. doi: 10.3389/fendo.2018.00613. eCollection 2018.
2
Technosphere insulin: defining the role of Technosphere particles at the cellular level.吸入型胰岛素：在细胞水平上定义吸入型微粒的作用。
J Diabetes Sci Technol. 2009 May 1;3(3):545-54. doi: 10.1177/193229680900300320.
3
Pharmaceutical particle engineering via spray drying.通过喷雾干燥进行药物颗粒工程
Pharm Res. 2008 May;25(5):999-1022. doi: 10.1007/s11095-007-9475-1. Epub 2007 Nov 28.
本文引用的文献
1
An open, randomized, parallel-group study to compare the efficacy and safety profile of inhaled human insulin (Exubera) with metformin as adjunctive therapy in patients with type 2 diabetes poorly controlled on a sulfonylurea.一项开放、随机、平行组研究，比较吸入型人胰岛素（依克苏泌）与二甲双胍作为辅助治疗药物，对使用磺脲类药物血糖控制不佳的2型糖尿病患者的疗效和安全性。
Diabetes Care. 2006 Jun;29(6):1282-7. doi: 10.2337/dc05-1879.
2
JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice.英国联合学会临床实践中预防心血管疾病指南2：联合英国学会指南
Heart. 2005 Dec;91 Suppl 5(Suppl 5):v1-52. doi: 10.1136/hrt.2005.079988.
3
Advanced approaches in insulin delivery.
Curr Pharm Biotechnol. 2005 Oct;6(5):387-95. doi: 10.2174/138920105774370599.
4
Inhaled insulin improves glycemic control when substituted for or added to oral combination therapy in type 2 diabetes: a randomized, controlled trial.吸入胰岛素替代口服联合治疗或添加到口服联合治疗中时可改善2型糖尿病患者的血糖控制：一项随机对照试验。
Ann Intern Med. 2005 Oct 18;143(8):549-58. doi: 10.7326/0003-4819-143-8-200510180-00005.
5
Dose response of inhaled dry-powder insulin and dose equivalence to subcutaneous insulin lispro.吸入型干粉胰岛素的剂量反应及与皮下注射赖脯胰岛素的剂量等效性。
Diabetes Care. 2005 Oct;28(10):2400-5. doi: 10.2337/diacare.28.10.2400.
6
The effect of insulin antibodies on the metabolic action of inhaled and subcutaneous insulin: a prospective randomized pharmacodynamic study.胰岛素抗体对吸入和皮下注射胰岛素代谢作用的影响：一项前瞻性随机药效学研究。
Diabetes Care. 2005 Sep;28(9):2161-9. doi: 10.2337/diacare.28.9.2161.
7
Efficacy of inhaled insulin in patients with type 2 diabetes not controlled with diet and exercise: a 12-week, randomized, comparative trial.
Diabetes Care. 2005 Aug;28(8):1922-8. doi: 10.2337/diacare.28.8.1922.
8
Use of inhaled insulin in a basal/bolus insulin regimen in type 1 diabetic subjects: a 6-month, randomized, comparative trial.1型糖尿病患者在基础/餐时胰岛素治疗方案中使用吸入胰岛素：一项为期6个月的随机对照试验。
Diabetes Care. 2005 Jul;28(7):1630-5. doi: 10.2337/diacare.28.7.1630.
9
Inhaled insulin for diabetes mellitus.用于糖尿病的吸入式胰岛素。
Am J Health Syst Pharm. 2005 Jul 1;62(13):1359-64. doi: 10.2146/ajhp040249.
10
Time-action profile of inhaled insulin in comparison with subcutaneously injected insulin lispro and regular human insulin.吸入胰岛素与皮下注射赖脯胰岛素和常规人胰岛素的时间-作用曲线比较。
Diabetes Care. 2005 May;28(5):1077-82. doi: 10.2337/diacare.28.5.1077.
Zotero 插件